Once youve completed pregnancy (and breastfeeding, if applicable), your provider can help you safely resume treatment if appropriate
Cagrilintide vs semaglutide (Wegovy/Ozempic) Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways Weight loss: Cagrilintide alone: 10-12% Semaglutide alone: 10-15% Similar efficacy monotherapy Gastric emptying: Cagrilintide: Very strong delay Semaglutide: Moderate delay Cagrilintide more powerful Side effects: Cagrilintide: More GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Cagrilintide harder to tolerate for some Availability: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved, widely available Semaglutide easier to obtain currently Combination potential: Synergistic together (CagriSema) 15-25% weight loss combined Best of both mechanisms Verdict: Similar monotherapy efficacy, but combine for maximum results

Increased oxidative stress in the brain has a strong association with neurodevelopmental disorders such as autism (ASD), motor tics, Tourettes syndrome (TS), and attention-deficit hyperactivity disorder (ADHD)
Cell Rep Med 6 (2025)
Key References Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al
Semaglutide boosts insulin release, slows stomach emptying, and reduces hunger